2635-64-5 Usage
Description
Pomalidomide Impurity 3, also known as Hydrolyzed Pomalidomide M11, is an impurity of pomalidomide (P688200). Pomalidomide is a thalidomide derivative and a potent inhibitor of TNF-α production. It is characterized by its anti-inflammatory and antitumor properties.
Used in Pharmaceutical Industry:
Pomalidomide Impurity 3 is used as an active pharmaceutical ingredient (API) for the development of drugs targeting inflammation and cancer. Its role in the pharmaceutical industry is crucial due to its potential therapeutic effects on various diseases, including multiple myeloma.
Used in Research and Development:
Pomalidomide Impurity 3 serves as a valuable compound in research and development for understanding the mechanisms of action, pharmacokinetics, and pharmacodynamics of pomalidomide. This knowledge aids in the optimization of drug formulations and the development of novel therapeutic strategies.
Used in Quality Control and Regulatory Compliance:
Pomalidomide Impurity 3 is utilized in the quality control processes of pharmaceutical manufacturing to ensure the purity, safety, and efficacy of the final drug product. It is also essential for meeting regulatory requirements and guidelines for drug approval and post-marketing surveillance.
Check Digit Verification of cas no
The CAS Registry Mumber 2635-64-5 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 2,6,3 and 5 respectively; the second part has 2 digits, 6 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 2635-64:
(6*2)+(5*6)+(4*3)+(3*5)+(2*6)+(1*4)=85
85 % 10 = 5
So 2635-64-5 is a valid CAS Registry Number.
2635-64-5Relevant articles and documents
Processes for the preparation of 4-amino-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione compounds
-
Page/Page column 11, (2008/06/13)
The present invention provides new processes for the preparation of unsubstituted and substituted 4-amino-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione compounds which are usefuil, for example, for preventing or treating diseases or conditions related to an abnormally high level or activity of TNF-α. The invention can provide improved and/or efficient processes for the commercial production of unsubstituted and substituted 4-amino-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione compounds, including, but not limited to, unsubstituted 4-amino-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione.
